Relay Therapeutics, Inc.

RLAY

—

Advanced chart & tools →

Relay Therapeutics, Inc.RLAY

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-1.61

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$15.36M

Net income

$-276.48M

Net margin

-1800.6%

Gross margin

—

Dividends & financials

Relay Therapeutics, Inc. (RLAY) reported revenue of $15.36M and net income of $-276.48M, or $-1.61 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.